A prospective randomized trial of tapered-cuff endotracheal tubes with intermittent subglottic suctioning in preventing ventilator-associated pneumonia in critically ill patients

被引:35
|
作者
Mahmoodpoor, Ata [1 ]
Hamishehkar, Hadi [2 ]
Hamidi, Masoud [1 ]
Shadvar, Kamran [1 ]
Sanaie, Sarvin [3 ]
Golzari, Samad E. J. [1 ]
Khan, Zahid Hussain [4 ]
Nader, Nader D. [5 ]
机构
[1] Tabriz Univ Med Sci, Dept Anesthesiol & Crit Care Med, Tabriz, Iran
[2] Tabriz Univ Med Sci, Dept Clin Pharm, Tabriz, Iran
[3] Tabriz Univ Med Sci, TB & Lung Res Ctr, Tabriz, Iran
[4] Univ Tehran Med Sci, Dept Anesthesiol & Crit Care Med, Tehran, Iran
[5] SUNY Buffalo, Dept Anesthesiol, 252 Farber Hall,3435 Main St, Buffalo, NY 14214 USA
关键词
TaperGuard endotracheal tubes; Ventilator-associated pneumonia; Intensive care units; SECRETION DRAINAGE; CONTINUOUS ASPIRATION; INTUBATED PATIENTS; CLINICAL-TRIAL; MORTALITY; LEAKAGE;
D O I
10.1016/j.jcrc.2016.11.007
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Endotracheal tube placement is necessary for the control of the airway in patients who are mechanically ventilated. However, prolonged duration of endotracheal tube placement contributes to the development of ventilator-associated pneumonias (VAPs). The aim of this study was to evaluate whether subglottic suctioning using TaperGuard EVAC tubes was effective in decreasing the frequency of VAP. Methods: A total of 276 mechanically ventilated patients for more than 72 hours were randomly assigned to group E (EVAC tube) and group C (conventional tube). All patients received routine care including VAP prevention measures during their intensive care unit stay. In group E, subglottic suctioning was performed every 6 hours. Outcome variables included incidence VAP, intensive care unit length of stay, and mortality. Results: Frequency of intraluminal suction, mechanical ventilation-free days, reintubation, the ratio of arterial oxygen partial pressure to fractional inspired oxygen and mortality rate were similar between the 2 groups (P > .05). The mean cuff pressure in group E was significantly less than that in group C (P < .001). Ventilator-associated pneumonia was significantly less in group E compared with group C (P = .015). Conclusion: The use of intermittent subglottic secretion suctioning was associated with a significant decrease in the incidence of the VAP in critically ill patients. However, larger multicenter trials are required to arrive at a concrete decision on routine usage of TaperGuard tubes in critical care settings. Published by Elsevier Inc.
引用
收藏
页码:152 / 156
页数:5
相关论文
共 50 条
  • [31] Monitoring of endotracheal tube cuff pressure in occurrence of ventilator associated pneumonia in neuro-critically ill patients
    Dina Zidan
    Eslam Mahmoud Ali Ali Oweida
    Tayseer Mahmoud Zaitoun
    Emad Hamdy Hamouda Mohammed
    The Egyptian Journal of Bronchology, 19 (1):
  • [32] Ventilator-associated pneumonia in critically ill patients with COVID-19
    Maes, Mailis
    Higginson, Ellen
    Pereira-Dias, Joana
    Curran, Martin D.
    Parmar, Surendra
    Khokhar, Fahad
    Cuchet-Lourenco, Delphine
    Lux, Janine
    Sharma-Hajela, Sapna
    Ravenhill, Benjamin
    Hamed, Islam
    Heales, Laura
    Mahroof, Razeen
    Solderholm, Amelia
    Forrest, Sally
    Sridhar, Sushmita
    Brown, Nicholas M.
    Baker, Stephen
    Navapurkar, Vilas
    Dougan, Gordon
    Scott, Josefin Bartholdson
    Morris, Andrew Conway
    CRITICAL CARE, 2021, 25 (01)
  • [33] Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients
    Cook, DJ
    Walter, SD
    Cook, RJ
    Griffith, LE
    Guyatt, GH
    Leasa, D
    Jaeschke, RZ
    Brun-Buisson, C
    ANNALS OF INTERNAL MEDICINE, 1998, 129 (06) : 433 - 440
  • [34] Ventilator-associated pneumonia in critically ill patients with intensive antibiotic usage
    Bor, Canan
    Demirag, Kubilay
    Okcu, Ozlem
    Cankayali, Ilkin
    Uyar, Mehmet
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (06) : 1441 - 1446
  • [35] Mimivirus is not a frequent cause of ventilator-associated pneumonia in critically ill patients
    Vanspauwen, M. J.
    Schnabel, R. M.
    Bruggeman, C. A.
    Drent, M.
    van Mook, W. N. K. A.
    Bergmans, D. C. J. J.
    Linssen, C. F. M.
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (10) : 1836 - 1841
  • [36] Impact of hyperoxemia on mortality in critically ill patients with ventilator-associated pneumonia
    Six, Sophie
    Rouze, Auahita
    Pauly, Olivier
    Poissy, Julien
    Wallet, Frederic
    Preau, Sebastien
    Nseir, Saad
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (21)
  • [37] Treatment of Achromobacter Ventilator-Associated Pneumonia in Critically Ill Trauma Patients
    Wood, G. Christopher
    Jonap, Brittany L.
    Maish, George O., III
    Magnotti, Louis J.
    Swanson, Joseph M.
    Boucher, Bradley A.
    Croce, Martin A.
    Fabian, Timothy C.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (02) : 120 - 125
  • [38] Pharmacokinetics and pharmacodynamics of levofloxacin in critically ill patients with ventilator-associated pneumonia
    Benko, Ria
    Matuz, Maria
    Doro, Peter
    Peto, Zoltan
    Molnar, Anna
    Hajdu, Edit
    Nagy, Erzsebet
    Gardi, Janos
    Soos, Gyongyver
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (02) : 162 - 168
  • [39] Treatment of Achromobacter Ventilator-Associated Pneumonia in Critically Ill Trauma Patients
    Jonap, Brittany
    Wood, G.
    Maish, George
    Magnotti, Louis
    Swanson, Joseph
    Boucher, Bradley
    Croce, Martin
    Fabian, Timothy
    CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [40] Antibiotic stewardship in critically ill patients with suspected ventilator-associated pneumonia
    Yoshimura, Jumpei
    Hashimoto, Hideki
    Yamakawa, Kazuma
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (20)